colon cancer News
Most Popular colon cancer Story
Roche dealt setback as Avastin misses trial goal
Roche's stock dropped 10 percent in Swiss trading following the announcement that Avastin did not meet the primary endpoint in a highly-anticipated Phase III trial. The trial tested whether Avastin... Read more...
Latest Headlines
- April 22, 2009
- May 16, 2008
- October 3, 2007
- September 14, 2007
- January 25, 2007
- January 9, 2007
- October 11, 2006
- August 31, 2006
- June 20, 2006
- February 12, 2006
- November 8, 2005
- October 5, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
